LLY
Eli Lilly and Company
1,152.40$
+1.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.7% | +6.3% | -5.9% | +7.6% | +3.8% | +9.9% | +15.4% | +0.8% | +19.6% | +32.0% | +44.7% | |
| – | +2.1% | +13.4% | -22.1% | +5.3% | +0.8% | +16.1% | +33.4% | -9.3% | +6.8% | +18.9% | +25.5% | |
| – | +1.6% | +4.0% | +0.1% | +8.3% | +4.7% | +8.3% | +10.2% | +4.3% | +23.4% | +35.4% | +49.1% | |
| – | +1.3% | +10.7% | -4.0% | -0.9% | +10.8% | +6.8% | +16.0% | +3.8% | +29.5% | +18.0% | +21.4% | |
| – | -1.3% | -3.1% | -2.4% | -7.2% | +4.7% | -2.2% | +4.6% | -1.2% | +14.4% | +17.2% | +36.4% | |
| – | -0.2% | +2.7% | -3.1% | -4.3% | +7.5% | +2.1% | +10.4% | +1.4% | +22.6% | +17.6% | +30.3% | |
| – | +7.9% | +7.8% | +9.8% | +41.8% | -0.4% | +20.2% | +10.0% | +9.1% | +24.7% | +62.2% | +69.7% | |
| – | +8.3% | +14.9% | +21.5% | +7.8% | +65.2% | -10.2% | -5.5% | -2.4% | +46.5% | +60.7% | +1.9% | |
| – | -7.0% | +20.9% | -31.7% | +59.7% | +43.1% | +37.3% | -14.9% | +10.6% | -3.7% | +93.5% | +102.9% | |
| – | -37.4% | +66.8% | +275.7% | -77.9% | +18.6% | +65.0% | -44.6% | -2.1% | +134.0% | +59.1% | +143.6% | |
| – | +0.7% | +13.7% | -107.5% | – | +157.4% | -25.5% | -9.9% | +11.9% | -16.1% | +102.1% | +94.9% | |
| – | -3.3% | +15.5% | -19.0% | +35.0% | +24.7% | +29.2% | -9.8% | +7.7% | -1.1% | +77.7% | +83.5% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.